ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,609Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 517

$714K Total Retail Price of All Prescriptions

Rank: 39 out of 517

157 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 6,273 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ZETIA 422 416 1 72
LOSARTAN POTASSIUM 294 281 2 17
ISOSORBIDE MONONITRATE ER 242 230 3 70
JANUVIA 202 193 4 43
AMLODIPINE BESYLATE 201 171 5 2
DIOVAN 192 187 6 20
SIMVASTATIN 189 179 7 1
BENICAR 181 170 8 105
GUANFACINE HCL 171 171 R 9 315
TERAZOSIN HCL 124 124 10 94
LYRICA 123 121 11 122
ACARBOSE 121 105 12 191
GABAPENTIN 119 118 13 13
GLIMEPIRIDE 117 117 14 35
TERBUTALINE SULFATE 109 104 15 263
CLONIDINE HCL 106 106 16 59
IBANDRONATE SODIUM 104 104 17 129
WELCHOL 97 80 18 232
FAMOTIDINE 96 92 19 44
SPIRIVA 95 92 20 84
NAMENDA 94 82 21 52
DONEPEZIL HCL 91 86 22 28
OMEPRAZOLE 89 83 23 3
FUROSEMIDE 81 80 24 9
FLUOCINONIDE 76 75 25 86
CLOPIDOGREL 75 67 26 47
LIDODERM 69 69 27 49
VYTORIN 68 67 28 148
METOPROLOL TARTRATE 64 52 29 18
PLAVIX 63 59 30 62
BYSTOLIC 63 63 30 114
ATELVIA 62 62 32 108
CARVEDILOL 60 60 33 26
ULORIC 56 54 34 238
METFORMIN HCL 55 55 35 4
LEVOTHYROXINE SODIUM 55 55 35 6
ALLOPURINOL 51 46 37 37
ATORVASTATIN CALCIUM 50 50 38 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.